Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nippon Kayaku evaluates novel doxorubicin preparation

Oct. 11, 1996

No Comments

Antitumor antibiotics from the Kitasato Institute

Oct. 11, 1996

No Comments

FK-317, a new antitumor antibiotic from Fujisawa

Oct. 11, 1996

No Comments

U.S. Bioscience and Schering-Plough revise Ethyol agreement

Oct. 4, 1996

No Comments

VX-853 for MDR reversal receives patent coverage

Oct. 4, 1996

No Comments

Inhibitors of endothelial cell proliferation from Sumitomo

Oct. 4, 1996

No Comments

Human Genome Sciences discloses novel approach to malignancy

Oct. 4, 1996

No Comments

Anticancer MMP inhibitor enters clinical trials

Oct. 4, 1996

No Comments

Takeda's anticancer drug pipeline reviewed

Sep. 27, 1996

No Comments

Promising preclinical and clinical results for Genta's lead antisense compound

Sep. 27, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

Nippon Kayaku evaluates novel doxorubicin preparation

Antitumor antibiotics from the Kitasato Institute

FK-317, a new antitumor antibiotic from Fujisawa

U.S. Bioscience and Schering-Plough revise Ethyol agreement

VX-853 for MDR reversal receives patent coverage

Inhibitors of endothelial cell proliferation from Sumitomo

Human Genome Sciences discloses novel approach to malignancy

Anticancer MMP inhibitor enters clinical trials

Takeda's anticancer drug pipeline reviewed

Promising preclinical and clinical results for Genta's lead antisense compound

Today's news in brief

Today's news in brief

Regulatory actions for Oct. 31, 2024

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

Cureverse, Angelini ink $360M deal for oral Alzheimer’s drug

Cancer RSS

Cancer
RSS